Literature DB >> 2823034

Radiation therapy in the treatment of chemodectomas.

J B Konefal1, M V Pilepich, G J Spector, C A Perez.   

Abstract

Twenty-six patients with chemodectomas were treated with radiation therapy from 1961 to 1983 and followed for at least 4 years. In 16 glomus tympanicum lesions treated primarily with radiation, long-term control was achieved in all (follow-up 4-24 years, mean 10.5). Fifteen of 16 had no clinical evidence of disease at time of death or last follow-up, and one patient had recurrent but stable disease at 10 years and died of an unrelated illness 19 years after treatment. Eight of the glomus tympanicum lesions were referred for radiation therapy with persistent disease after multiple surgical procedures. Two had extensive skull and intracranial involvement at the time of radiation. Six patients with glomus jugulare lesions were treated with radiation. Four achieved long-term control, and two died of their disease. In addition, two glomus vagal and one carotid body tumor were treated with palliative intent. One glomus tympanicum lesion was treated with preoperative radiation and resection. Chemodectoma was the cause of death in 4 of 25 patients--3 from intracranial extension and 1 from lung and mediastinal metastases. All four patients were referred for radiation with metastases or extensive bone involvement at the skull base. Radiation appears to be effective in achieving long-term clinical control of chemodectomas. Adequately treated volume should be determined with arteriography and/or contrast-enhanced computer tomography, allowing for geometric margins. Doses in the range of 4,500 to 5,000 cGy delivered in about 5 weeks are recommended.

Entities:  

Mesh:

Year:  1987        PMID: 2823034     DOI: 10.1288/00005537-198711000-00016

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  9 in total

1.  Nasopharyngeal extension of glomus tympanicum: an unusual clinical and imaging manifestation.

Authors:  S Hirunpat; K Riabroi; C Dechsukhum; V Atchariyasathian; W Tanomkiat
Journal:  AJNR Am J Neuroradiol       Date:  2006-10       Impact factor: 3.825

2.  Radiotherapy in the management of temporal bone chemodectoma.

Authors:  W M Mendenhall; J T Parsons; S P Stringer; N J Cassisi; G T Singleton; R R Million
Journal:  Skull Base Surg       Date:  1995

3.  An update on the surgical treatment of temporal bone paraganglioma.

Authors:  K S Moe; D Li; T E Linder; S Schmid; U Fisch
Journal:  Skull Base Surg       Date:  1999

4.  Surgical therapy of glomus vagale tumors.

Authors:  J D Browne; U Fisch; A Valavanis
Journal:  Skull Base Surg       Date:  1993

5.  Long-term results of surgery for temporal bone paraganglioma.

Authors:  M Gjuric; L Seidinger; M E Wigand
Journal:  Skull Base Surg       Date:  1996

6.  Cervical paragangliomas: neurovascular surgical risk and therapeutic management.

Authors:  J Paris; F Facon; J M Thomassin; M Zanaret
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-07-06       Impact factor: 2.503

7.  Surgery of Glomus Jugulare Tumors.

Authors:  Roberto Pareschi; Stefano Righini; Domenico Destito; Aldo Falco Raucci; Stefano Colombo
Journal:  Skull Base       Date:  2003-08

8.  Transcanal endoscopic treatment of benign middle ear neoplasms.

Authors:  Daniele Marchioni; Matteo Alicandri-Ciufelli; Federico Maria Gioacchini; Marco Bonali; Livio Presutti
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-02-03       Impact factor: 2.503

9.  Role of irradiation in combined treatment of head and neck paragangliomas at the Centre of Oncology in Krakow between 1970-2005.

Authors:  Magdalena Pęcak; Elżbieta Pluta; Marcin Hetnał; Renata Wróbel-Radecka; Agnieszka Szadurska; Piotr Brandys; Andrzej Kukiełka; Tomasz Dąbrowski; Tomasz Walasek; Jan Skołyszewski
Journal:  Contemp Oncol (Pozn)       Date:  2014-06-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.